Highlighted by the increased presence of X4 viruses in PAH patients, interactions of X4 viruses with endothelial CXCR4 co-receptors are likely driving pulmonary vascular inflammation. This evidence concerns the gene CXCR4 and pulmonary arterial hypertension.